UK markets closed

CytomX Therapeutics, Inc. (CTMX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.5100+0.0300 (+2.03%)
At close: 04:00PM EDT
1.5400 +0.03 (+1.99%)
After hours: 07:42PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
No. of analysts8898
Avg. Estimate-0.13-0.22-0.83-0.91
Low estimate-0.38-0.39-1.59-1.47
High estimate0.22-0.13-0.21-0.41
Year ago EPS-0.37-0.37-1.51-0.83
Revenue estimateCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
No. of analysts8898
Avg. Estimate19.91M12.12M59.08M43.77M
Low estimateN/AN/AN/AN/A
High estimate40M20M110M89.2M
Year ago sales17.14M18.16M53.16M59.08M
Sales growth (year/est)16.20%-33.30%11.10%-25.90%
Earnings history30/03/202229/06/202229/09/202230/12/2022
Est. EPS-0.36-0.36-0.31-0.24
Actual EPS-0.37-0.37-0.35-0.43
Difference-0.01-0.01-0.04-0.19
Surprise %-2.80%-2.80%-12.90%-79.20%
EPS trendCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
Current estimate-0.13-0.22-0.83-0.91
7 days ago-0.25-0.23-0.97-0.86
30 days ago-0.25-0.23-0.97-0.86
60 days ago-0.25-0.23-0.97-0.86
90 days ago-0.25-0.23-0.94-0.81
EPS revisionsCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
Up last 7 days4352
Up last 30 days4352
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1234
Growth estimatesCTMXIndustrySector(s)S&P 500
Current qtr.64.90%N/AN/AN/A
Next qtr.40.50%N/AN/AN/A
Current year45.00%N/AN/AN/A
Next year-9.60%N/AN/AN/A
Next 5 years (per annum)-0.90%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A